SCHEMBL19260675

SCHEMBL19260675

Nc1c2ccccc2nc2cc(OCCCN3CCCC3)cc(C(=O)O)c12

nearest known ligand 0.50

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 11/20 0.50
KCNH2 Q12809 10/20 0.50
ADRA1A P35348 5/20 0.50
KDM4E B2RXH2 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
ALDH1A1 P00352 1/20 0.50
HTR4 Q13639 1/20 0.48
GCGR P47871 1/20 0.48
ACP1 P24666 1/20 0.47
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL19260686 0.78 KCNH2 (0.43) HRH3KCNH2ADRA1AKDM4ESMN1; SMN2
SCHEMBL19260636 0.74 HRH3 (0.56) HRH3KCNH2ADRA1AKDM4ESMN1; SMN2
Formic Acid SCHEMBL19260676 0.73 KDM4E (0.46) HRH3KCNH2ADRA1AKDM4ESMN1; SMN2
SCHEMBL3131412 0.72 MAOB (0.59) HRH3KDM4ESMN1; SMN2ALDH1A1NPC1
SCHEMBL19260720 0.72 HRH3 (0.54) HRH3KCNH2ADRA1AKDM4ESMN1; SMN2
Trifluoroacetic Acid SCHEMBL19260825 0.72 HRH3 (0.53) HRH3KCNH2ADRA1AKDM4ESMN1; SMN2
Hydrochloric Acid SCHEMBL3127783 0.72 MAOB (0.58) HRH3KDM4ESMN1; SMN2ALDH1A1NPC1
SCHEMBL20720695 0.71 HRH3 (0.47) HRH3KCNH2ADRA1AACP1
SCHEMBL19260826 0.71 HRH3 (0.51) HRH3KCNH2ADRA1AKDM4ESMN1; SMN2
SCHEMBL28405124 0.70 ACP1 (0.57) HRH3KCNH2ADRA1AHTR4ACP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3416963-A1 HISTONE METHYLTRANSFERASE INHIBITORS Global Blood Therapeutics, Inc. (US) 2018-12-26 EP disclosed
WO-2017142947-A1 HISTONE METHYLTRANSFERASE INHIBITORS GLOBAL BLOOD THERAPEUTICS, INC. (US) 2017-08-24 WO disclosed